You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 205081


✉ Email this page to a colleague

« Back to Dashboard


NDA 205081 describes MILNACIPRAN HYDROCHLORIDE, which is a drug marketed by Amneal Pharms, Hetero Labs Ltd V, and Oryza, and is included in three NDAs. It is available from one supplier. Additional details are available on the MILNACIPRAN HYDROCHLORIDE profile page.

The generic ingredient in MILNACIPRAN HYDROCHLORIDE is milnacipran hydrochloride. There are twenty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the milnacipran hydrochloride profile page.
Summary for 205081
Tradename:MILNACIPRAN HYDROCHLORIDE
Applicant:Amneal Pharms
Ingredient:milnacipran hydrochloride
Patents:0
Pharmacology for NDA: 205081
Suppliers and Packaging for NDA: 205081
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205081 ANDA Amneal Pharmaceuticals LLC 65162-091 65162-091-06 60 TABLET in 1 BOTTLE (65162-091-06)
MILNACIPRAN HYDROCHLORIDE milnacipran hydrochloride TABLET;ORAL 205081 ANDA Amneal Pharmaceuticals LLC 65162-092 65162-092-06 60 TABLET in 1 BOTTLE (65162-092-06)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength12.5MG
Approval Date:Apr 22, 2016TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG
Approval Date:Apr 22, 2016TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Apr 22, 2016TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.